비뇨의학 Urology Digest ISSN:2713-7910(Print) 2733-5453(Online)

Handelsman DJ et al., Androgen Misuse and Abuse, Endocr Rev, 2021

Bennink HJTC et al., The loss of estradiol by androgen deprivation in prostate cancer patients shows the importance of estrogens in males, J Endocrine Soc, 2024

Gilbert DC et al., A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design, Clin Oncol, 2023

Langley RE et al., Transdermal oestradiol for androgen suppression in prostate cancer : long-term cardiovascular outcomes from the randomised prostate adenocarcinoma transcutaneous hormone (PATCH) trial programme, Lancet, 2021

Bennink HJTC et al., Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi.) Eur Urol Open Sci, 2021

Russell N et al., Short-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial, Eur J Endocrinol, 2018

Russell N et al., Estradiol for the mitigation of adverse effects of androgen deprivation therapy, Endocr Relat Cancer, 2017